AUBN
Auburn National Bancorporation, Inc.
There isn't enough reported data to score AUBN yet.
JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
AUBN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
AUBN's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like AUBN.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
AUBN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $25.91 | -0.1% |
| Current | 10x | $25.93 | — |
| Fair | 14x | $34.22 | +32% |
| Expensive | 21x | $53.36 | +106% |
Historical ranges are pointers, not guarantees.
AUBN has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
AUBN Forward outlook
There aren't enough analyst estimates for AUBN to show an outlook.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
AUBN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.49 | +21% |
| Q2 2026 | $2.41 | +26% |
| Q1 2026 | $2.27 | +20% |
| Q4 2025 | $2.08 | +13% |
| Q3 2025 | $2.05 | +720% |
| Q2 2025 | $1.91 | +961% |
| Q1 2025 | $1.89 | +722% |
| Q4 2024 | $1.84 | +360% |
AUBN has the edge over JPM on earnings, with stronger typical year-over-year growth.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
AUBN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $9M | +7% |
| Q2 2026 | $8.8M | +7.8% |
| Q1 2026 | $8.6M | +11% |
| Q4 2025 | $8.5M | +8.4% |
| Q3 2025 | $8.4M | +10% |
| Q2 2025 | $8.1M | +6.9% |
| Q1 2025 | $7.8M | +3.3% |
| Q4 2024 | $7.8M | +1140% |
AUBN's revenue has grown year over year for nine quarters in a row: $9M last quarter, up 7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 35% | +1.1 points |
| Q2 2026 | 33% | +4.7 points |
| Q1 2026 | 32% | +7.8 points |
| Q4 2025 | 25% | -5.5 points |
| Q3 2025 | 34% | +4.3 points |
| Q2 2025 | 29% | -0.6 points |
| Q1 2025 | 25% | +4.3 points |
| Q4 2024 | 31% | +904 points |
AUBN's operating margin was 35% last quarter, up 1.1 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over AUBN on profitability, with a higher operating margin.
AUBN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $1.5M | -29% |
| Q1 2026 | $2.5M | -3.5% |
| Q3 2025 | $4.1M | +117% |
| Q2 2025 | $2.1M | -30% |
| Q1 2025 | $2.6M | -15% |
| Q3 2024 | $1.9M | -43% |
| Q2 2024 | $3M | +23% |
| Q1 2024 | $3.1M | -37% |
AUBN has the stronger cash trend. Its trailing FCF is down 9.6% versus its history, compared with JPM at down 229%.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
AUBN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -6.9K shares |
| 1 year | -0.3% | -10.8K shares |
| 3 years | -0.3% | -11.2K shares |
| 5 years | -1.2% | -42.4K shares |
| Available history | -3% | -108K shares |
AUBN has 3M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $195,000 |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | $130,000 |
| Q2 2023 | $35,000 |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over AUBN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
AUBN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.3x | Net Cash |
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -2.0x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | -1.7x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -1.5x | Net Cash |
AUBN has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
AUBN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.5 | Neutral |
| Stochastic | 53.4 | Neutral |
AUBN's weekly RSI is 49 (neutral) and its Stochastic is 53 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
AUBN PE vs Financial Services Sector
| Metric | AUBN | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 13x | 20% below |
| PE % | 17 | 63 | 46 pts below |
AUBN has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
AUBN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.4 | 1.9% below |
| 20 week MA | $26.6 | 2.5% below |
| 50 week MA | $25.5 | 1.6% above |
| 100 week MA | $24.5 | 5.9% above |
| 200 week MA | $22.7 | 14% above |
AUBN has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 14% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over AUBN on trend strength, trading above more of its moving averages.
AUBN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $53.8 | $42.6 | -21% |
| 2021 | $42.6 | $32.1 | -24% |
| 2022 | $32.1 | $23.3 | -27% |
| 2023 | $23.3 | $21.3 | -8.7% |
| 2024 | $21.3 | $23.9 | +12% |
| 2025 | $23.9 | $27.0 | +13% |
| 2026 YTD | $27.0 | $25.9 | -3.8% |
AUBN has finished lower in four of the last six years. It's down 3.8% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over AUBN on returns for 2026, with the stronger performance.